‹ ›

This content requires a premium subscription.
Please log in or subscribe to continue.
Artwork for MPR Weekly Dose 102 - COVID-19 vaccine contraindication; Final results for COVID-19 antiviral; Entadfi approved; CAR T-cell REMS change; New approval for psoriatic arthritis
MPR Weekly Dose

MPR Weekly Dose 102 - COVID-19 vaccine contraindication; Final results for COVID-19 antiviral; Entadfi approved; CAR T-cell REMS change; New approval for psoriatic arthritis
30
00:00:00 / 00:14:21